antiarrhythmic


Also found in: Thesaurus, Medical, Encyclopedia.

an·ti·ar·rhyth·mic

 (ăn′tē-ə-rĭth′mĭk, ăn′tī-)
adj.
Preventing or alleviating irregularities in the force or rhythm of the heart.
n.
An antiarrhythmic drug.

antiarrhythmic

(ˌæntɪeɪˈrɪðmɪk)
n
(Pharmacology) a drug that corrects irregular heartbeat
adj
(Pharmacology) pertaining to drugs that correct irregular heartbeat
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.antiarrhythmic - a drug used to treat an abnormal heart rhythmantiarrhythmic - a drug used to treat an abnormal heart rhythm
amiodarone, Cordarone - an antiarrhythmic drug (trade name Cordarone) that has potentially fatal side effects and is used to control serious heart rhythm problems only when safer agents have been ineffective
encainide, Enkaid - antiarrhythmic drug (trade name Enkaid) used to treat life-threatening arrhythmias but increases the risk of sudden death in heart attack patients
flecainide, Tambocor - oral antiarrhythmic medication (trade name Tambocor) used as a last resort in treating arrhythmias; increases the risk of sudden death in heart attack patients
medicament, medication, medicinal drug, medicine - (medicine) something that treats or prevents or alleviates the symptoms of disease
mexiletine, Mexitil - antiarrhythmic drug (trade name Mexitil) used to treat ventricular arrhythmias
Quinidex, quinidine, Quinora - cardiac drug (trade names Quinidex and Quinora) used to treat certain heart arrhythmias
tocainide, Tonocard - antiarrhythmic drug (trade name Tonocard) used to treat ventricular arrhythmias when less dangerous drugs have failed
Translations

antiarrhythmic

adj & n antiarrítmico
References in periodicals archive ?
(NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that an abstract highlighting the results of the SPECTRUM study evaluating Brinavess(vernakalant hydrochloride, IV), the Company's antiarrhythmic drug for the rapid conversion of recent onset atrial fibrillation (AF), was selected for a poster presentation at the European Society of Cardiology (ESC) 2019 Congress taking place August 31 - September 4, 2019, in Paris.
In collaboration with members of the UCLA Cardiovascular Research Laboratory (CVRL), Numerate will use the funds to support the discovery of novel, small molecule drug candidates that address the need for a well-tolerated antiarrhythmic therapy for the treatment and prevention of ventricular tachycardias and fibrillation (VT/VF).
The results from a 10-year randomized trial known as the CABANA trial (Catheter Ablation versus Antiarrhythmic Drug trial for Atrial Fibrillation) have recently been released.
According to the company, Brinavess (vernakalant HCl, IV) is an antiarrhythmic drug that acts preferentially in the atria by prolonging atrial refractoriness and slowing impulse conduction in a rate-dependent fashion.
This poster presentation highlights reduced hospitalization in patients treated with Brinavess, Correvio's antiarrhythmic drug for the rapid conversion of recent onset atrial fibrillation, from a clinical survey assessing patients with acute AF at the Hillel Yaffe Medical Center located in Hadera, Israel.
Bretylium Tosylate Injection is indicated for the prophylaxis and therapy of ventricular fibrillation; treatment of life-threatening ventricular arrhythmia that has failed to respond to first-line antiarrhythmic agents.
Due to the fact that antiarrhythmic medications are associated with the adverse effects of proarrhythmic or refractory hypotension, the use of these agents may further deteriorate the condition of patients with tachyarrhythmias.
(9) Women and patients treated with antiarrhythmic drugs were also at higher risk of AF after ablation.
Continued treatment with an antiarrhythmic drug in the drug-arm patients, compared with no drug treatment in the ablated patients, "is absolutely the explanation" for the observed difference in quality of life, she said.
Electrophysiologists from the US provide 21 chapters on anatomy in clinical electrophysiology, membrane and cellular electrophysiology, mechanisms of tachycardias, the basic electrophysiology study, basic principles in clinical electrophysiology, and various disorders, as well as pacemaker and implantable cardioverter defibrillator (ICD) indications, function, and troubleshooting; noninvasive diagnostic testing; and antiarrhythmic drugs.
In these conditions, patients undergoing antiarrhythmic therapy with drugs known to prolong the QT interval pose a real diagnostic challenge.